Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Urology Oncology|June 26, 2026
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial CarcinomaRyan Dillon, Robert Jones, Aude Fléchon, et al.
The Pediatric Infectious Disease Journal|September 25, 2012
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trialRosalyn Singleton, Jay Wenger, Joseph A Klejka, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Sylvia H Yeh, et al.
Pediatrics|August 13, 2014
Reducing catheter-associated urinary tract infections: a quality-improvement initiativeKatherine Finn Davis, Ann M Colebaugh, Benjamin L Eithun, et al.
Vaccine|November 4, 2025
Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infantsShelly Senders, Piotr Korbal, Mary Kline, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 1, 2019
Apneic Oxygenation As a Quality Improvement Intervention in an Academic PICUNatalie Napolitano, Elizabeth K Laverriere, Nancy Craig, et al.
Vaccine|October 27, 2012
A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in BrazilLily Yin Weckx, Allison Thompson, Eitan Naaman Berezin, et al.
The Pediatric Infectious Disease Journal|October 19, 2013
13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Shelly Senders, et al.
Vaccine|February 24, 2023
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trialKevin Cannon, Jose F Cardona, Kari Yacisin, et al.
The Pediatric Infectious Disease Journal|September 15, 2021
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United StatesShelly Senders, Nicola P Klein, Erik Lamberth, et al.
Pageof 4